Selective mode antimicrobial resistance therapeutics

Selmod is a startup with a mission dedicated to the development of disruptive antibacterial and antifungal therapies needed to address the critical unmet need for antimicrobial resistance, or AMR for short.

Products, services, technology

With our 3 preclinical assets we perform the lead optimization, full pharmacological profiling, and pharmacodynamic efficacy studies in rodent and none-rodent mammalian animal models are our objectives towards a fully characterized pre-clinal IND candidates.

Cooperation possibilities

With our first-in-class approach, we perform preclinical research on new targets or new modalities by a new mode of action.

Our drug candidates are active against multi-resistant clinical isolates in infection in-vivo studies and are based on new IP-protected chemical modalities.

Some insights
Additional address info
  • Switzerland Innovation Park Basel Area
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland
Key business

You may also be interested in